Braemar Hotels & Resorts (BHR) Sidoti Micro-Cap Virtual Conference summary
Event summary combining transcript, slides, and related documents.
Sidoti Micro-Cap Virtual Conference summary
9 Jan, 2026Strategic focus and portfolio overview
Focused on luxury hotels with high barriers to entry and strong RevPAR growth over 30 years.
Portfolio includes 15 hotels, $2.2 billion in assets, and $700 million in annual revenue.
Balanced mix: 60% resort, 40% urban, with major brands like Ritz-Carlton and Four Seasons.
Recent asset sales and capital recycling to optimize portfolio and reduce non-luxury exposure.
Ongoing renovations and repositioning, including Cameo Beverly Hills and several resort upgrades.
Industry trends and performance
Luxury hotel segment outperforms other chain scales in rate growth and resilience.
Occupancy at 95% of pre-COVID levels; ADRs up 25% from 2019, driving RevPAR 18% above pre-pandemic.
Urban hotel demand expected to rise as work-from-home policies are repealed.
Hotel supply growth will be less than half historical levels for the next four years, supporting rate increases.
Resort ADRs remain 40% above 2019, with mean reversion signaling renewed growth ahead.
Financial management and capital allocation
Refinanced loans to lower interest costs and extend maturities, with more refinancing planned for 2025.
Portfolio is 75% floating rate debt, positioning for increased cash flow as rates decline.
Plans to sell one or two hotels in 2024, using proceeds for preferred equity redemption, share buybacks, or potential internalization.
$50 million share buyback authorization in place.
Added experienced board members to support transactions and restructuring.
Latest events from Braemar Hotels & Resorts
- 2025 saw modest RevPAR growth, net loss, and a sale process, with resorts outperforming.BHR
Q4 20253 Mar 2026 - Urban hotels outperformed as asset sales and refinancing strengthened the balance sheet.BHR
Q2 20242 Feb 2026 - Urban hotels outperformed as asset sales and refinancing strengthened liquidity.BHR
Q3 202415 Jan 2026 - Virtual annual meeting faces legal challenge over board nominations and voting procedures.BHR
Proxy Filing8 Dec 2025 - Q4 RevPAR rose 1.9% with strong bookings; 2025 outlook remains positive.BHR
Q4 20243 Dec 2025 - Board urges support for its nominees and proposals amid proxy contest and governance focus.BHR
Proxy Filing1 Dec 2025 - Proxy campaign targets board nominees as annual meeting approaches, highlighting governance and risk.BHR
Proxy Filing1 Dec 2025 - Proxy campaign opposes Blackwells' nominees and outlines key risks ahead of July 2024 vote.BHR
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, pay, auditor, and review a potential company sale.BHR
Proxy Filing1 Dec 2025